Gefitinib - CAS# 184475-35-2 Size:Solid 2 mg 1'-biphenyl]-3-carboxylic acid

1'-biphenyl]-3-carboxylic acid

TDZD8 (10 μM) induces LKB1 nuclear-cytoplasm translocation

CAS Number: 98079-52-8

FPH1 was suggested to be supplemented into the culture medium on day 1 and 5 at a concentration of 15-20 μM to induce functional proliferation of primary human hepatocytes in vitro

A randomized Phase II study of veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in BRCA1/2 metastatic breast cancer: design and rationale

Gefitinib - CAS# 184475-35-2 Size:Solid 2 mg 1'-biphenyl]-3-carboxylic acidGefitinib, also known as ZD1839, is an anilinoquinazoline with antineoplastic activity. Gefitinib inhibits the catalytic activity of numerous tyrosine kinases including the epidermal growth factor receptor (EGFR), which may result in inhibition of tyrosine kinase dependent tumor growth. Specifically, this agent competes with the binding of ATP to the tyrosine kinase domain of EGFR, thereby inhibiting receptor autophosphorylation and resulting in